Related references
Note: Only part of the references are listed.Development of New Tuberculosis Drugs: Translation to Regimen Composition for Drug-Sensitive and Multidrug-Resistant Tuberculosis
Jacqueline P. Ernest et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021 (2021)
Intrapulmonary Pharmacokinetics of First-line Anti-tuberculosis Drugs in Malawian Patients With Tuberculosis
Andrew D. McCallum et al.
CLINICAL INFECTIOUS DISEASES (2021)
Biomarker-Guided Individualization of Antibiotic Therapy
Linda B. S. Aulin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Host-directed therapy to combat mycobacterial infections*
Gul Kilinc et al.
IMMUNOLOGICAL REVIEWS (2021)
Model-based Target Pharmacology Assessment (mTPA): An Approach Using PBPK/PD Modeling and Machine Learning to Design Medicinal Chemistry and DMPK Strategies in Early Drug Discovery
Emile P. Chen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
One Size Fits All? Not in In Vivo Modeling of Tuberculosis Chemotherapeutics
Hee-Jeong Yang et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)
History and Future Perspectives on the Discipline of Quantitative Systems Pharmacology Modeling and Its Applications
Karim Azer et al.
FRONTIERS IN PHYSIOLOGY (2021)
Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial
Robert S. Wallis et al.
LANCET RESPIRATORY MEDICINE (2021)
Tuberculosis endotypes to guide stratified host-directed therapy
Andrew R. DiNardo et al.
MED (2021)
Therapeutic host-directed strategies to improve outcome in tuberculosis
C. Young et al.
MUCOSAL IMMUNOLOGY (2020)
Integration of Omics Data Sources to Inform Mechanistic Modeling of Immune-Oncology Therapies: A Tutorial for Clinical Pharmacologists
Georgia Lazarou et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Effects of host-directed therapies on the pathology of tuberculosis
Liana Tsenova et al.
JOURNAL OF PATHOLOGY (2020)
Immune correlates of tuberculosis disease and risk translate across species
Mushtaq Ahmed et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Drug-Drug-Gene Interaction Model of Metformin and Cimetidine in Healthy Adults and Renally Impaired Individuals
Nina Hanke et al.
CLINICAL PHARMACOKINETICS (2020)
Functional Inhibition of Host Histone Deacetylases (HDACs) Enhances in vitro and in vivo Anti-mycobacterial Activity in Human Macrophages and in Zebrafish
Josimar D. Moreira et al.
FRONTIERS IN IMMUNOLOGY (2020)
Rifabutin Is Bactericidal against Intracellular and Extracellular Forms of Mycobacterium abscessus
Matt D. Johansen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Inhibiting Histone Deacetylases in Human Macrophages Promotes Glycolysis, IL-1β, and T Helper Cell Responses toMycobacterium tuberculosis
Donal J. Cox et al.
FRONTIERS IN IMMUNOLOGY (2020)
Ibrutinib suppresses intracellular mycobacterium tuberculosis growth by inducing macrophage autophagy
Yunlong Hu et al.
JOURNAL OF INFECTION (2020)
Anti-tuberculosis effect of isoniazid scales accurately from zebrafish to humans
Rob C. van Wijk et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
A QSP model of prostate cancer immunotherapy to identify effective combination therapies
Roberta Coletti et al.
SCIENTIFIC REPORTS (2020)
y Tuberculosis causes highly conserved metabolic changes in human patients, mycobacteria-infected mice and zebrafish larvae
Yi Ding et al.
SCIENTIFIC REPORTS (2020)
Mathematical model and tool to explore shorter multi-drug therapy options for active pulmonary tuberculosis
John Fors et al.
PLOS COMPUTATIONAL BIOLOGY (2020)
A lung-on-chip model of early Mycobacterium tuberculosis infection reveals an essential role for alveolar epithelial cells in controlling bacterial growth
Vivek V. Thacker et al.
ELIFE (2020)
Systems Pharmacology: Defining the Interactions of Drug Combinations
J. G. Coen van Hasselt et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)
Metformin Alters Human Host Responses to Mycobacterium tuberculosis in Healthy Subjects
Ekta Lachmandas et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study
Krina Mehta et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Predicting Metabolism from Gene Expression in an Improved Whole-Genome Metabolic Network Model of Danio rerio
Leonie van Steijn et al.
ZEBRAFISH (2019)
IMPACT-TB*: A Phase II Trial Assessing the Capacity of Low Dose Imatinib to Induce Myelopoiesis and Enhance Host Anti-Microbial Immunity Against Tuberculosis. *Imatinib Mesylate per Oral As a Clinical Therapeutic for TB
Cynthia R. Giver et al.
BLOOD (2019)
A Double Negative Feedback Loop between mTORC1 and AMPK Kinases Guarantees Precise Autophagy Induction upon Cellular Stress
Marianna Holczer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Adjunctive Host-Directed Therapy With Statins Improves Tuberculosis-Related Outcomes in Mice
Noton K Dutta et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Applications of Quantitative Systems Pharmacology in Model-Informed Drug Discovery: Perspective on Impact and Opportunities
Erica L. Bradshaw et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2019)
Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up
Y. Ma et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2018)
Combined chemical genetics and data-driven bioinformatics approach identifies receptor tyrosine kinase inhibitors as host-directed antimicrobials
Cornelis J. Korbee et al.
NATURE COMMUNICATIONS (2018)
c-Abl-TWIST1 Epigenetically Dysregulate Inflammatory Responses during Mycobacterial Infection by Co-Regulating Bone Morphogenesis Protein and miR27a
Kasturi Mahadik et al.
FRONTIERS IN IMMUNOLOGY (2018)
Histone deacetylase 6 inhibitor enhances resistance to Mycobacterium tuberculosis infection through innate and adaptive immunity in mice
Xiaolei Wang et al.
PATHOGENS AND DISEASE (2018)
Novel insights into the pharmacometabonomics of first-line tuberculosis drugs relating to metabolism, mechanism of action and drug-resistance
Ilse Du Preez et al.
DRUG METABOLISM REVIEWS (2018)
Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment
Nicholas R. Degner et al.
CLINICAL INFECTIOUS DISEASES (2018)
Dissection of the host-pathogen interaction in human tuberculosis using a bioengineered 3-dimensional model
Liku B. Tezera et al.
ELIFE (2017)
New Paradigm for Translational Modeling to Predict Long-term Tuberculosis Treatment Response
I. H. Bartelink et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2017)
Host-Directed Therapeutic Strategies for Tuberculosis
Afsal Kolloli et al.
FRONTIERS IN MEDICINE (2017)
Protection and pathology in TB: learning from the zebrafish model
Annemarie H. Meijer
SEMINARS IN IMMUNOPATHOLOGY (2016)
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Payam Nahid et al.
CLINICAL INFECTIOUS DISEASES (2016)
Adaptation of Mycobacterium tuberculosis to Impaired Host Immunity in HIV-Infected Patients
Nicholas D. Walter et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Cytokines and Chemokines in Mycobacterium tuberculosis Infection
Racquel Domingo-Gonzalez et al.
MICROBIOLOGY SPECTRUM (2016)
Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm
Tawanda Gumbo et al.
CLINICAL INFECTIOUS DISEASES (2015)
Testing Tuberculosis Drug Efficacy in a Zebrafish High-Throughput Translational Medicine Screen
Anita Ordas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
The DNA Damage-Regulated Autophagy Modulator DRAM1 Links Mycobacterial Recognition via TLR-MYD88 to Autophagic Defense
Michiel van der Vaart et al.
CELL HOST & MICROBE (2014)
Statin Therapy Reduces the Mycobacterium tuberculosis Burden in Human Macrophages and in Mice by Enhancing Autophagy and Phagosome Maturation
Suraj P. Parihar et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Metformin as adjunct antituberculosis therapy
Amit Singhal et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
The development of a fully-integrated immune response model (FIRM) simulator of the immune response through integration of multiple subset models
Sirus Palsson et al.
BMC SYSTEMS BIOLOGY (2013)
Population Pharmacokinetics of Metformin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus: Simulation of Doses According to Renal Function
Janna K. Duong et al.
CLINICAL PHARMACOKINETICS (2013)
Imatinib-Sensitive Tyrosine Kinases Regulate Mycobacterial Pathogenesis and Represent Therapeutic Targets against Tuberculosis
Ruth J. Napier et al.
CELL HOST & MICROBE (2011)
Host-Pathogen Interactions Made Transparent with the Zebrafish Model
Annemarie H. Meijer et al.
CURRENT DRUG TARGETS (2011)
Contribution of CD8+ T cells to control of Mycobacterium tuberculosis infection
Dhruv Sud et al.
JOURNAL OF IMMUNOLOGY (2006)
The human immune response to Mycobacterium tuberculosis in lung and lymph node
S Marino et al.
JOURNAL OF THEORETICAL BIOLOGY (2004)
Six-month therapy with aerosolized interferon-γ for refractory multidrug-resistant pulmonary tuberculosis
WJ Koh et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2004)
A model to predict cell-mediated immune regulatory mechanisms during human infection with Mycobacterium tuberculosis
JE Wigginton et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
